Literature DB >> 22581967

The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Eva d'Hennezel1, Khalid Bin Dhuban, Troy Torgerson, Ciriaco A Piccirillo, Ciriaco Piccirillo.   

Abstract

Immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome is a rare disorder in humans caused by germ-line mutations in the FOXP3 gene, a master transcriptional regulator for the development of CD4 regulatory T (Treg) cells. This T cell subset has global inhibitory functions that maintain immune homeostasis and mediate self-tolerance. Treg developmental deficiency or dysfunction is a hallmark of IPEX. It leads to severe, multi-organ, autoimmune phenomena including enteropathy, chronic dermatitis, endocrinopathy and other organ-specific diseases such as anaemia, thrombocytopenia, hepatitis and nephritis. In this review, the genetic, immunological and clinical characteristics of IPEX syndrome are described, and the impact of heritable mutations on the function of Treg cells highlighted.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581967     DOI: 10.1136/jmedgenet-2012-100759

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  50 in total

1.  IPEX Syndrome, FOXP3 and Cancer.

Authors:  Runhua Liu; Silin Li; Wei-Hsiung Yang; Lizhong Wang
Journal:  J Syndr       Date:  2013-06

Review 2.  Atopic dermatitis in children: clinical features, pathophysiology, and treatment.

Authors:  Jonathan J Lyons; Joshua D Milner; Kelly D Stone
Journal:  Immunol Allergy Clin North Am       Date:  2014-11-21       Impact factor: 3.479

3.  Constitutive activation of MEK1 promotes Treg cell instability in vivo.

Authors:  Jitao Guo; Jianhua Zhang; Xuejie Zhang; Zhongmei Zhang; Xundong Wei; Xuyu Zhou
Journal:  J Biol Chem       Date:  2014-10-31       Impact factor: 5.157

4.  Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound.

Authors:  Raymond J Louie; Queenie K-G Tan; Jennifer B Gilner; R Curtis Rogers; Noelle Younge; Stephanie B Wechsler; Marie T McDonald; Barbara Gordon; Christopher A Saski; Julie R Jones; Shelley J Chapman; Roger E Stevenson; John W Sleasman; Michael J Friez
Journal:  Am J Med Genet A       Date:  2017-03-20       Impact factor: 2.802

Review 5.  Regulatory T Cells: the Many Faces of Foxp3.

Authors:  Peter Georgiev; Louis-Marie Charbonnier; Talal A Chatila
Journal:  J Clin Immunol       Date:  2019-09-02       Impact factor: 8.317

6.  FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  Jessica L Hwang; Soo-Young Park; Honggang Ye; May Sanyoura; Ashley N Pastore; David Carmody; Daniela Del Gaudio; Janna F Wilson; Craig L Hanis; Xiaoming Liu; Gil Atzmon; Benjamin Glaser; Louis H Philipson; Siri Atma W Greeley
Journal:  Pediatr Diabetes       Date:  2017-11-29       Impact factor: 4.866

7.  Extremely Early Onset IPEX Syndrome Caused by a Novel Small Exonic Deletion in FOXP3.

Authors:  Erika Smith; Siri Atma W Greeley; Honggang Ye; Troy R Torgerson; Reed Dimmitt; Prescott Atkinson; Joseph Philips; Frederick Goldman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

8.  Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.

Authors:  Khalid Bin Dhuban; Eva d'Hennezel; Emil Nashi; Amit Bar-Or; Sadiye Rieder; Ethan M Shevach; Satoshi Nagata; Ciriaco A Piccirillo
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

9.  A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells.

Authors:  Frédéric Van Gool; Michelle L T Nguyen; Maxwell R Mumbach; Ansuman T Satpathy; Wendy L Rosenthal; Simone Giacometti; Duy T Le; Weihong Liu; Todd M Brusko; Mark S Anderson; Alexander Y Rudensky; Alexander Marson; Howard Y Chang; Jeffrey A Bluestone
Journal:  Immunity       Date:  2019-01-29       Impact factor: 31.745

10.  Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome.

Authors:  Ester Rosári Raphaelli Dal Ben; Carine Hartmann do Prado; Talita Siara Almeida Baptista; Moisés Evandro Bauer; Henrique Luiz Staub
Journal:  J Clin Immunol       Date:  2013-01-29       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.